Ir para o conteúdo

The Lancet Diabetes & Endocrinology

@thelancetendo.bsky.social did:plc:b4o27tf7dzv6yrxdoevn7qtz

Your leading source of international, cutting-edge research, review, and opinion in clinical #diabetes and #endocrinology. IF=36·3. 🌐 thelancet.com/journals/landia/home

No Bluesky desde

Seguidores
1.865
Seguindo
751
Posts
1.297
Dias nos rankings
0

Resumo

The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) é um usuário do Bluesky desde 3 fevereiro 2025. Tem 1.865 seguidores, segue 751 contas e publicou 1.297 posts.

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

  • European Association for the Study of Diabetes@easdnews.bsky.social

    🔬 Don’t miss this important session! Join Prof. Chantal Mathieu for a Lab Talk at #EASD2026. 📅 2 Oct |🕙10:15 - 10:45 CEST | 📍 Arena Hear about her #lab, her #research & how she leads her team. Make sure to join the conversation in the Arena! It's going to be a great one! #Diabetes #LabTalk

    Ver post
  • European Association for the Study of Diabetes@easdnews.bsky.social

    🔴 Happening now at #EASD2026. Today's session draws on insights from a major Phase 3 efficacy trial: TRIUMPH-2 of retatrutide in people with obesity & T2D with: 🎤 John Wilding 🎤 Juan Pablo Frias 🎤 Elif Ekinci 🎤 Elisabeth Van Rossum Chaired by Arya M. Sharma 📍 Happening now in the Paris Hall

    Ver post
  • European Association for the Study of Diabetes@easdnews.bsky.social

    Early detection saves lives. EU Commissioner Olivér Várhelyi launched the “#KnowYourNumbers” campaign for the first-ever #EUScreeningWeek. @easdnews.bsky.social, @escardio.bsky.social,@easoobesity.bsky.social &@eudiabetesforum.bsky.social welcome the proposal. 👉 health.ec.europa.eu/know-your-nu...

    Ver post
  • NIHR ARC East Midlands@arc-em.bsky.social

    A new framework published today in @thelancetendo.bsky.social sets out 35 core outcomes for testing interventions to modify the progression of #type2diabetes. Researchers from @arc-em.bsky.social and @uniofleicester.bsky.social are part of the team behind it. 🔗 arc-em.nihr.ac.uk/news/type-2-...

    Ver post
  • Will Herrington@willkidney.bsky.social

    Almost all u need 2 know about the remarkable clinical effects of #SGLT2i on the kidney in a wide ranging IPD metaanalysis (covers effects by albuminuria, predicted eGFR dip and novel exploratory eGFR slope methods). Please do read it! @oxpop.bsky.social @martinlandray.bsky.social

    Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.

Esta conta não bloqueia ninguém.